Company profile: HighLife Medical
1.1 - Company Overview
Company description
- Provider of transcatheter mitral valve replacement solutions for patients with mitral valve regurgitation. Offers the HighLife TSMVR Solution, a system designed for moderate to severe mitral regurgitation patients at high surgical risk; technology is currently in clinical evaluation.
Products and services
- HighLife Transcatheter Mitral Valve Replacement (TMVR) System: A mitral valve replacement engineered for high-surgical-risk patients with moderate to severe mitral regurgitation, enabling catheter-based therapy
- TMVR Clinical Evaluation Program: A clinical-stage assessment examining HighLife’s mitral valve replacement technology for treating mitral valve regurgitation in moderate to severe, high-surgical-risk patients
- Transcatheter MR Treatment Technology Development: The company architects transcatheter mitral valve replacement technology focused on treating patients suffering from mitral valve regurgitation, prioritizing high surgical risk cases
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to HighLife Medical
Celera
HQ: United States
Website
- Description: Provider of molecular diagnostic products and services that leverage knowledge of human variability to personalize disease management, enabling hospitals and clinical laboratories to detect, characterize, monitor, and select treatment for disease, including genotyping for infections diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Celera company profile →
Myocor
HQ: United States
Website
- Description: Provider of therapeutic cardiac technologies and evaluations to treat mitral regurgitation and heart failure, improving cardiac function. Offers the Coapsys System, a device and therapy for mitral valve insufficiency via a less invasive, off-pump, closed-heart procedure. Founded in 1996 and based in Minnesota.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Myocor company profile →
Contego Medical
HQ: United States
Website
- Description: Provider of novel embolic protection devices and integrated vascular intervention systems, including Paladin IEP carotid PTA balloons for protected stenting; Neuroguard IEP carotid stent and post-dilation systems; Excipio dual-mode thrombectomy devices with physician-controlled expandable baskets; and Vanguard IEP peripheral angioplasty balloons with integrated embolic protection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Contego Medical company profile →
enVVeno Medical
HQ: United States
Website
- Description: Provider of bioprosthetic devices for cardiovascular surgeries, including VenoValve, a surgically implanted one-way valve to restore proper blood flow in the femoral vein for patients with deep venous Chronic Venous Insufficiency (CVI), and enVVe, a non-surgical, transcatheter-based replacement venous valve for minimally invasive treatment of CVI in the deep veins of the leg.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full enVVeno Medical company profile →
WhiteSwell
HQ: Ireland
Website
- Description: Provider of science-driven solutions to improve treatment of acute decompensated heart failure, addressing a leading cause of hospitalization and emergency room visits by investigating the therapeutic potential of the lymphatic system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full WhiteSwell company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for HighLife Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to HighLife Medical
2.2 - Growth funds investing in similar companies to HighLife Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for HighLife Medical
4.2 - Public trading comparable groups for HighLife Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →